DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Just a few weeks after Dexcom’s Stelo became the first over ... Like Stelo, Lingo takes the form of a patch with a tiny needle that pierces the skin and is worn on the back of the arm for ...

It takes the form of a patch with a small needle that pierces the skin and is worn on the back of the arm for up to 15 days, communicating glucose readings to a smartphone. Dexcom is focused on ...

I cleaned the back of my right arm, placed Dexcom's applicator there, pressed the button and the sensor popped right on.

With the new system, a wearable, tubeless product provides up to three days of nonstop insulin delivery without the need to handle a needle ... glucose monitor. The Dexcom Stelo Glucose Biosensor ...

Currently, only one model of CGM systems – Dexcom G6 CGM – is subsidised ... themselves with a needle many times a day ... or their parents have to sacrifice their careers to go to school ...

Dexcom; Diabetes Canda; Eli Lilly; GSK; HLS Therapeutics; Janssen; Master Clinician Alliance; MDBriefcase; Merck; Medtronic; Moderna;... Both Dr Kim and I attended ADA 2024. We went over all our ...

Investors have been bearish on DexCom's numbers all this past year. The opportunity in diabetes care, however, remains significant in the long run. The launch of glucose monitor Stelo should ...

DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels. But the stock has been performing poorly this year amid ...